The most controversial decision in FDA history...

This story is almost too ridiculous to believe... April 8, 2015 The most controversial decision in FDA history... Dear Rude Awakening Reader, Artificial growth hormone, antibiotics, and pus are just a few of the things researchers recently uncovered in a "certain type of milk" sold at thousands of locations nationwide. Today we are revealing the shocking story that got two Fox News reporters fired and prompted the FDA to remove one of its top researchers. I know... this isn't the type of information you're used to seeing in The Rude Awakening. But this story is too important for you to miss... even if it's almost too ridiculous to believe. In the next few minutes, you are about to discover the truth about what's been called "the most controversial decision in the FDA's history." You don't want to miss this. Click here for the entire story. Regards, Greg Guenthner Managing editor, The Rude Awakening The Rude Awakening is committed to protecting and respecting your privacy. We do not rent or share your email address. By submitting your email address, you consent to Agora Financial delivering daily email issues and advertisements. To end your Rude Awakening e-mail subscription and associated external offers sent from The Rude Awakening, click here. Please read our Privacy Statement. For any further comments or concerns please email us at rude@agorafinancial.com. If you are you having trouble receiving your Rude Awakening subscription, you can ensure its arrival in your mailbox by whitelisting The Rude Awakening. © 2015 Agora Financial, LLC. 808 Saint Paul Street, Baltimore MD 21202. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in any security they personally recommend to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.